Cargando…
New anti–coagulant therapies set to revitalise clinical haemotology practice
Autores principales: | J, AALBERS, P, WAGENAAR, E, KLUG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107720/ https://www.ncbi.nlm.nih.gov/pubmed/21135980 |
Ejemplares similares
-
FDA committee unanimously recommends approval of dabigatran etexilate for stroke prevention in atrial fibrillation
por: J, Aalbers, et al.
Publicado: (2010) -
South African experts comment on FDA approval of dabigatran inatrial fibrillation
por: E, Klug, et al.
Publicado: (2011) -
Comparison of ivabradine plus β-blockers versus β-blocker therapy only
por: Aalbers, J
Publicado: (2010) -
Chronic heart failure treatment benefits from pro-BNP-directed therapy
por: J, Aalbers
Publicado: (2011) -
Micafungin as antifungal prophylaxis in non-transplanted haemotological patients
por: Villaescusa, Teresa, et al.
Publicado: (2020)